Erratum to: Osteonecrosis of the jaw (ONJ) in renal cell cancer patients after treatment including zoledronic acid or denosumab [PDF]
Vittorio Fusco +2 more
openalex +1 more source
Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis
Background: Osteoporotic hip fractures are on the raise in the world. Denosumab and zoledronic acid are among the commonly used current anti-osteoporotic medications to reduce hip fractures.
P Madhuchandra, S Nandeesh, K P Raju
doaj +1 more source
Adherence and preference of intravenous zoledronic acid for osteoporosis versus other bisphosphonates [PDF]
María José Fobelo Lozano +1 more
openalex +1 more source
Acute Iridocyclitis Associated With Intravenous Zoledronic Acid: A Case Report [PDF]
Anvitha Ankireddypalli +1 more
openalex +1 more source
Use of Zoledronic Acid in a Neonate with Subcutaneous Fat Necrosis Complicated with Severe, Refractory Hypercalcemia [PDF]
Maria Angela Militello +5 more
openalex +1 more source
Erratum: The bisphosphonate zoledronic acid impairs membrane localisation and induces cytochrome c release in breast cancer cells [PDF]
S G Senaratne, Janine Mansi, K W Colston
openalex +1 more source
Zoledronic acid overcomes chemoresistance and immunosuppression of malignant mesothelioma [PDF]
Iris C. Salaroglio +6 more
openalex +1 more source

